Facebook

Overcoming Barriers to Access

Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.

5. December 2016.
|
RCEP

RCEP trade deal negotiators must reject terms that would harm access to medicines

Negotiators from the 16 countries in the Regional Comprehensive Economic Partnership (RCEP) meet in Tangerang, Indonesia, starting today. Read more

 

Access Barriers: The Issues

© Juan Carlos Tomasi

Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.

» Read more

Featured multimedia

Kala Azar: Still Waiting
Some three decades ago, a mystery disease spread throughout Sudan and what is now South Sudan, decimating communities, sewing fear, and killing scores...

Tags: Sudan, kala azar, visceral leishmaniasis, neglected diseases, R&D

↑ To top